Real Time Coverage Advancing Precision Medicine Annual Conference, Philadelphia PA November 1,2 2024
Reporter: Stephen J. Williams, Ph.D.
Source: https://www.advancingprecisionmedicine.com/apm-annual-conference-and-exhibition-in-philadelphia/
This event will be covered by the LPBI Group on Twitter. Follow on
using the following meeting hashtags
#AdvancingPM #precisionmedicine
The Advancing Precision Medicine (APM) Annual Conference 2024 will take place at the Pennsylvania Convention Center in Philadelphia, November 1-2, 2024. Located in the heart of the biopharma ecosystem and with easy access to some of the most renowned academic and research institutions in the world, the APM Annual Conference 2024 will attract all segments of the precision medicine landscape.
The event will consist of two parallel tracks composed of keynote addresses, panel discussions and fireside chats which will encourage audience participation. Over the course of the two-day event leaders from industry, healthcare, regulatory bodies, academia and other pertinent stakeholders will share an intriguing and broad scope of content.
his event will consist of three immersive tracks, each crafted to explore the multifaceted dimensions of precision medicine. Delve into Precision Oncology, where groundbreaking advancements are reshaping the landscape of cancer diagnosis and treatment. Traverse the boundaries of Precision Medicine Outside of Oncology, as we probe into the intricate interplay of genetics, lifestyle, and environment across a spectrum of diseases and conditions including rare disease, cardiology, ophthalmology, and neurodegenerative disease. Immerse yourself in AI for Precision Medicine, where cutting-edge technologies are revolutionizing diagnostics, therapeutics, and patient care. Additionally, explore the emerging frontiers of Spatial Biology and Mult-Omics, where integrated approaches are unraveling the complexities of biological systems with unprecedented depth and precision.
Whether you are a seasoned researcher, a dedicated clinician, or a visionary industry professional, this conference serves as a vibrant hub of knowledge exchange, collaboration, and innovation. Elevate your expertise, expand your network, and chart the course of your career trajectory amidst a community of like-minded individuals. Join us as we embark on this transformative journey, where the possibilities are as limitless as the potential of precision medicine itself.
Agenda – What’s on when
7:30 – 8:25
Registration and Check-in Meeting Room 203 Philadelphia Convention Center
8:25 – 8:30
Welcome and Introduction
8:30 – 9:00
Opening Keynote
Daniel Rader, Penn Medicine and Children’s Hospital of Philadelphia
9:00 – 10:20
9:00-10:20
Diagnosis to Treatment – A Case Study in Non Small Cell Lung Cancer
Moderator: Jason Crites, Assurance Health Data
Miriam Bredella, NYU Lagone Health
Rob Dumanois, Thermo Fisher Scientific
Joe Lennerz, BostonGene
9:00-9:20
Scaling Precision Therapeutic Development for Rare Disease (CME Eligible)Landscape Overview (CME Eligible)
Marni Falk, CHOP
9:20-9:40
Prognostic Biomarkers and Preclinical Modeling – the Cost of Inaction (CME Eligible)
Stephen Ekker, University of Texas at Austin
9:40-10:00
Regulatory Perspective on Rare Disease Drug Approvals and Efficacy Endpoints (CME Eligible)
Christine Nguyen, FDA
10:00-10:20
FDA’s Regulatory Flexibility Beyond One Positive Adequate & Well-Controlled Trial (CME Eligible)
Frank Sasinowski, Hyman, Phelps & McNamara
10:20 – 10:50
Networking, Exhibits and Product Presentations
10:25-10:35 PRODUCT PRESENTATION 204C
The Genexus Integrated Sequencer System:
NGS Results in 24 hours for Oncology Genomic Profiling
Jeff Smith, Thermo Fisher Scientific
10:35-10:45 PRODUCT PRESENTATION 204A
Karen Lin, Natera
10:50 – 12:50
10:50-11:50
Who Needs Liquid Biopsy? Opportunities to Increase Access and Improve Outcomes
Nicole St. Jean, GSK
Phil Febbo, Veracyte, Inc.
Andrea Ferreira-Gonzalez, Virginia Commonwealth University
Lauren Leiman, BloodPAC
Nicole Sheahan, Global Colon Cancer Association
11:50-12:50
Advancing Digital Pathology and Precision Medicine – Where Are We Now?
Shruti Mathur, Genentech
Luke Benko, Roche Diagnostics
Kimberly Gasuad, JK Life Sciences
Eric Walk, PathAI
10:50-11:10
Real World Data vs Multi Modal Omics Data for Therapeutic Discovery (CME Eligible)
Adam Resnick, CHOP
11:10-11:30
Hakon Hakonarson, CHOP
11:30-11:50
NCATS Perspective on Success and Failures of Drug Repurposing for Rare Disease (CME Eligible)
PJ Brooks, NIH
11:50-12:10
Pharma Perspective and Realities (CME Eligible)
Sundeep Dugar, Rarefy Therapeutics
12:10-12:50
A Panel Discussion: Scaling Precision Therapeutic Development for Rare Disease (CME Eligible)
Marni Falk, CHOP
Stephen Ekker, University of Texas at Austin
Christine Nguyen, FDA
Frank Sasinowski, Hyman, Phelps & McNamara
Adam Resnick, CHOP
Hakon Hakonarson, CHOP
Sundeep Dugar, Rarefy Therapeutics
PJ Brooks, NIH
12:50 – 1:50
Lunch & Product Presentations
1:10-1:25 PRODUCT PRESENTATION 204C
The Power of ctDNA Testing in Therapy Selection and Recurrence Monitoring
Taylor Jensen, LabCorp
1:50 – 3:50
1:50-3:50
Unlocking the Next Quantum Leap in Precision Medicine – A Town Hall Discussion (CME Eligible)
Co-Chairs
Amanda Paulovich, Fred Hutchinson Cancer Center
Henry Rodriguez, NCI/NIH
Eric Schadt, Pathos
Participants
Ezra Cohen, Tempus
Jennifer Leib, Innovation Policy Solutions
Susan Monarez, ARPA-H
Nick Seddon, Optum Genomics
Giselle Sholler, Penn State Hershey Children’s Hospital
Janet Woodcock, Former FDA
1:50-2:50
Advancing Precision Medicine in Non-Oncology Therapeutic Areas
Moderator: Mike Montalto, Amgen
Scott Friedman, Mt. Sinai
Sana Syed, University of Virginia
Lei Zhao, Amgen
2:50-3:20
Towards a Precision Neuroimmunology Platform (CME Eligible)
Amit Bar-Or, Penn Medicine
3:20-3:50
3:50 – 4:20
Networking and Exhibits
4:20 – 6:15
4:20-4:45
Sarah Hersey, BMS
4:45-5:30
Realizing Novel Treatment Paradigms with ctDNA-MRD (CME Eligible)
Mark Roschewski, NCI
5:30-6:30
The Potential Benefits of Next-day NGS for the Future of Precision Oncology
Allison Eck, Doylestown Health
Harry Erba, Duke Cancer Institute
Jeff Smith, Thermo Fisher Scientific
4:20-4:45
Advancing Precision Medicine: Polygenic Risk Scores and Beyond (CME Eligible)
Dokyoon Kim, Penn Medicine
4:45-5:30
The Rocky Road to Clinical Trial Diversity (CME Eligible)
Ysabel Duron, The Latino Cancer Institute
Porscha Johnson, PJW Clinical Pharmacy Consulting
Victor LaGroon, Department of Veterans Affairs
5:30-6:15
In the Rising Age of Women’s Health, How Do We Build Diagnostics to Last?
Oriana Papin Zoghbi, AOADx
Sarah Huah, Johnson & Johnson
6:30 – 7:00
Evening Keynote
Reimagining Health Equity in the Era of Precision Medicine (CME Eligible)
Rick Kittles, Morehouse School of Medicine
7:00 – 7:45
Cocktail Networking Reception
November 02, 2024
8:00-8:55
Registration and Check-in Meeting Room 203 Philadelphia Convention Center
2012pharmaceutical
sjwilliamspa